Freenome Stock
Freenome is a biotechnology company focused on developing blood tests for the early detection of cancer. Its multiomics platform integrates data from genomics, proteomics, and other biological sources to identify cancer at its earliest stages through a simple blood draw.
Founded: 2014
For more Freenome stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Mike Nolan Chief Executive Officer |
| Riley Ennis Co-Founder and Chief Product Officer |
| Greg Chow Chief Financial Officer |
| Jimmy Lin, M.D., Ph.D. Chief Scientific Officer |
| Julie Tran Chief People Officer |
| Lance Baldo, M.D. Chief Medical Officer |
| Michael Ash Chief Commercial Officer |
